You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RARE Sale Disclosure
Horn Howard · SEC Form 4 · Filed Oct 19, 2026
Sale
Calculated transaction value
$107.9K
Horn Howard Chief Financial Officer
RARE
Transaction date
Oct 15, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed 4 days later
RARE daily price context
Close on/before transaction
$15.17
Oct 15, 2026
First close after public filing
$15.07
Oct 19, 2026
Return after filing · so far
+10.82%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,066 shares @ $15.27
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-425032
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$107.9K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE Current | Sale | Oct 15, 2026 | $107.9K |